{
    "disease_name": "Leukemia",
    "synonyms": ["Leukaemia", "Blood cancer"],
    "summary": "Leukemia is a group of blood cancers that start in the bone marrow and produce large numbers of abnormal white blood cells.",
    "causes": [
      "Genetic mutations activating oncogenes or deactivating tumor suppressor genes",
      "Exposure to ionizing radiation",
      "Exposure to petrochemicals such as benzene",
      "Prior chemotherapy",
      "Down syndrome and other chromosomal abnormalities",
      "Infection with human T-lymphotropic virus type 1 (HTLV-1)"
    ],
    "risk_factors": [
      "Smoking",
      "High-dose radiation exposure",
      "Occupational exposure to petrochemicals",
      "Family history of leukemia",
      "Older age",
      "Male sex"
    ],
    "symptoms": [
      "Fatigue",
      "Fever",
      "Frequent infections",
      "Easy bruising or bleeding",
      "Bone pain",
      "Pale skin",
      "Swollen lymph nodes or spleen"
    ],
    "diagnosis": [
      "Complete blood count (CBC)",
      "Bone marrow biopsy",
      "Genetic and chromosomal testing",
      "Imaging (MRI, CT, or ultrasound) for organ involvement"
    ],
    "treatments": [
      "Chemotherapy",
      "Radiation therapy",
      "Targeted therapy (e.g., imatinib for CML)",
      "Bone marrow or stem cell transplant",
      "Supportive and palliative care"
    ],
    "related_genes": [
      "BCR-ABL1",
      "SPRED1",
      "TP53",
      "BRCA2",
      "RUNX1"
    ],
    "subtypes": [
      {
        "name": "Acute lymphoblastic leukemia (ALL)",
        "typical_patients": "Children and adults over 65",
        "five_year_survival": "60–90%",
        "common_treatments": ["Chemotherapy", "Radiotherapy"]
      },
      {
        "name": "Chronic lymphocytic leukemia (CLL)",
        "typical_patients": "Adults over 55",
        "five_year_survival": "85%",
        "common_treatments": ["Chemotherapy", "Immunotherapy"]
      },
      {
        "name": "Acute myeloid leukemia (AML)",
        "typical_patients": "Mostly adults",
        "five_year_survival": "20%",
        "common_treatments": ["Chemotherapy"]
      },
      {
        "name": "Chronic myeloid leukemia (CML)",
        "typical_patients": "Adults",
        "five_year_survival": "90%",
        "common_treatments": ["Imatinib (Gleevec)"]
      }
    ],
    "epidemiology": {
      "global_cases_2015": 2300000,
      "global_deaths_2015": 353500,
      "most_common_in": "Children and older adults",
      "five_year_survival_rate": "67% (US 2014–2020)"
    },
    "relationships": [
      {"source": "Leukemia", "relation": "has_symptom", "target": "Fatigue"},
      {"source": "Leukemia", "relation": "has_cause", "target": "Ionizing radiation"},
      {"source": "Leukemia", "relation": "has_gene_association", "target": "BCR-ABL1"},
      {"source": "Chronic myeloid leukemia", "relation": "treated_with", "target": "Imatinib"},
      {"source": "Acute lymphoblastic leukemia", "relation": "treated_with", "target": "Chemotherapy"}
    ]
  }
  
